Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose and exercise training in iron-deficient non-anaemic chronic kidney disease
2018-000144-25Phase 4Unknown
- Sponsor
- King's College Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ferric carboxymaltose in iron deficiency anemia (IDA) and chronic kidney disease (CKD) (4 arms), sponsored by King's College Hospital. Primary endpoint: 6-minute walking distance. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2018-000144-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000144-25.